Substance P, a neuropeptide widely presented in the CNS and a substrate of DPP4, was found to be protective against AD by ameliorating Aβ-induced neuronal apoptosis in the brain secondary to the stimulation of non-amyloidogenic APP processing (Severini et al., 2016). This evidence concerns the gene APP and Alzheimer disease.